In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Ana Karina Nisperuza VidalDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0009-0002-6952-4278 Chenxiao WangDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0000-0001-7950-9288 Michaela J AllenDepartment of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Xiaofeng DingDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.
Jefferson Fernandes EvangelistaDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Yilin ChenDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.
Mst Shamima KhatunDepartment of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0009-0004-3889-0720 Micaela R Boxer WachlerDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Calder R EllsworthDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0000-0001-7111-525X Mohammad IslamuddinDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0000-0002-4929-8931 Robert BlairDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0000-0001-9616-9414 Jay K KollsDepartment of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0001-5151-6304 Derek A PociaskDepartment of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Xuebin QinDivision of Comparative Pathology, Tulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0000-0001-9875-983X Funding
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4MRole of Complement Activation in Severe COVID-19R01HL165265 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI QIN, XUEBIN · 2022 to 2025
$2.9MRenal Macrophage BiologyR01DK129881 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI Xuebin Qin · 2022 to 2026
$2.5MMAC formation and Cell-Specific Inflammasome Activation in COVID-19F31AI191758 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI ELLSWORTH, CALDER R · 2025 to 2025
$50kAmerican Heart Association-American Stroke Association 962950NHLBI NIH HHS R01 HL165265NIAID NIH HHS F31 AI191758NIDDK NIH HHS R01 DK129881NIH HHS P51 OD011104
6 · The paper itselfAbstract
Influenza A virus (IAV) remains a major cause of respiratory morbidity and mortality worldwide. However, the precise role of the RNA sensor Toll-like receptor 7 (TLR7) and its downstream signaling mediator, interferon regulatory factor 7 (IRF7), during IAV infection remains elusive. To address this gap, we utilized single-cell RNA sequencing (scRNA-seq) alongside
Indexed as
Influenza A virusInterferon Regulatory Factor-7Membrane GlycoproteinsOrthomyxoviridae InfectionsToll-Like Receptor 7AnimalsDendritic CellsDisease Models, AnimalFemaleLungMiceMice, Inbred C57BLMice, KnockoutSignal TransductionInterferon Regulatory Factor-7Irf7 protein, mouseMembrane GlycoproteinsTlr7 protein, mouseToll-Like Receptor 7antibody productioninfluenza A virus (IAV)interferon regulatory factor 7 (IRF7)interferon responseToll-like receptor 7 (TLR7)
Identifiers
PMID42797873
PMCPMC13611839
What OpenQuestion holds
Textmetadata
Read underepoch 390